🇺🇸 Intermittent, short infusion Cefepime in United States

Intermittent, short infusion Cefepime (Intermittent, short infusion Cefepime) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intermittent, short infusion Cefepime in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intermittent, short infusion Cefepime approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intermittent, short infusion Cefepime in United States?

The Alfred is the originator. The local marketing authorisation holder may differ — check the official source linked above.